Xencor (XNCR) Long-Term Investments (2015 - 2024)

Xencor (XNCR) reported Long-Term Investments of $43.8 million for Q2 2024, down 31.82% year-over-year from $64.2 million in Q3 2023, and up 0.51% quarter-over-quarter from $43.6 million in Q1 2024.

Xencor (XNCR) Long-Term Investments (2015 - 2024) Analysis & Trends

Xencor (XNCR) has 10 years of Long-Term Investments data on file, last reported at $43.8 million in Q2 2024.

  • Long-Term Investments for Q2 2024 came in at $43.8 million, down 31.82% year-over-year; the trailing twelve-month figure through Jun 2024 was $43.8 million (down 31.82% YoY), and the FY2023 annual result was $64.2 million, up 18.07% from the prior year.
  • Long-Term Investments improved to $43.8 million in Q2 2024 per XNCR's latest filing, from $43.6 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $64.2 million in Q2 2023 and troughed at $1.1 million in Q2 2020.
  • A 5-year average of $38.6 million and a median of $35.0 million in 2020 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2020 and 2023: Long-Term Investments plunged 99.05% in 2020, then jumped 106.3% in 2023.
  • A 5-year view of Long-Term Investments shows it stood at $16.1 million in 2020, then jumped by 94.52% to $31.3 million in 2021, then jumped by 73.96% to $54.4 million in 2022, then grew by 18.07% to $64.2 million in 2023, then plunged by 31.82% to $43.8 million in 2024.
  • Business Quant data shows XNCR's Long-Term Investments at $43.8 million in Q2 2024, $43.6 million in Q1 2024, and $64.2 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 43.78 Mn
Mar 31, 2024 43.56 Mn
Dec 31, 2023 64.21 Mn
Sep 30, 2023 64.21 Mn
Jun 30, 2023 64.21 Mn
Mar 31, 2023 54.21 Mn
Dec 31, 2022 54.38 Mn
Sep 30, 2022 31.12 Mn
Jun 30, 2022 31.12 Mn
Mar 31, 2022 31.26 Mn
Dec 31, 2021 31.26 Mn
Sep 30, 2021 16.58 Mn
Dec 31, 2020 16.07 Mn
Sep 30, 2020 31.77 Mn
Jun 30, 2020 1.15 Mn
Mar 31, 2020 38.23 Mn
Dec 31, 2019 71.53 Mn
Sep 30, 2019 74.00 Mn
Jun 30, 2019 120.97 Mn
Mar 31, 2019 172.47 Mn